Cita APA

Bendell, J. C., Montagut Viladot, C., Hurwitz, H., & Group, M. S. (2020). The McCAVE Trial: Vanucizumab plus mFOLFOX-6 versus bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal carcinoma (mCRC).

Citación estilo Chicago

Bendell, Johanna C., Clara Montagut Viladot, Herbert Hurwitz, y McCAVE Study Group. The McCAVE Trial: Vanucizumab Plus MFOLFOX-6 Versus Bevacizumab Plus MFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Carcinoma (mCRC). 2020.

Cita MLA

Bendell, Johanna C., Clara Montagut Viladot, Herbert Hurwitz, y McCAVE Study Group. The McCAVE Trial: Vanucizumab Plus MFOLFOX-6 Versus Bevacizumab Plus MFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Carcinoma (mCRC). 2020.